The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
APOHIDE Accelagen Pty Ltd
Product name
APOHIDE
Sponsor
Accepted date
Jul-2024
Active ingredients
oxybutynin hydrochloride
Proposed indication
Treatment of primary palmar hyperhydrosis
Application type
C (new indication)
Publication date
Jul-2024